MLTX
Price
$38.12
Change
+$0.07 (+0.18%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.41B
34 days until earnings call
PHVS
Price
$14.85
Change
-$0.10 (-0.67%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
805.36M
20 days until earnings call
Ad is loading...

MLTX vs PHVS

Header iconMLTX vs PHVS Comparison
Open Charts MLTX vs PHVSBanner chart's image
MoonLake Immunotherapeutics
Price$38.12
Change+$0.07 (+0.18%)
Volume$15.18K
Capitalization2.41B
Pharvaris
Price$14.85
Change-$0.10 (-0.67%)
Volume$117
Capitalization805.36M
MLTX vs PHVS Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. PHVS commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and PHVS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MLTX: $38.03 vs. PHVS: $14.85)
Brand notoriety: MLTX and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 120% vs. PHVS: 33%
Market capitalization -- MLTX: $2.41B vs. PHVS: $805.36M
MLTX [@Biotechnology] is valued at $2.41B. PHVS’s [@Biotechnology] market capitalization is $805.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 4 bearish.
  • PHVS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than PHVS.

Price Growth

MLTX (@Biotechnology) experienced а -4.54% price change this week, while PHVS (@Biotechnology) price change was -4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

MLTX is expected to report earnings on May 08, 2025.

PHVS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.41B) has a higher market cap than PHVS($805M). PHVS YTD gains are higher at: -22.535 vs. MLTX (-29.769). PHVS has higher annual earnings (EBITDA): -127.53M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. PHVS (305M). PHVS has less debt than MLTX: PHVS (117K) vs MLTX (2.83M). MLTX (0) and PHVS (0) have equivalent revenues.
MLTXPHVSMLTX / PHVS
Capitalization2.41B805M299%
EBITDA-141.71M-127.53M111%
Gain YTD-29.769-22.535132%
P/E RatioN/AN/A-
Revenue00-
Total Cash448M305M147%
Total Debt2.83M117K2,419%
TECHNICAL ANALYSIS
Technical Analysis
MLTXPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVCX15.140.16
+1.07%
Janus Henderson Mid Cap Value C
DAMDX26.94N/A
N/A
Dunham Monthly Distribution A
MAPOX109.02N/A
N/A
Mairs & Power Balanced
GPMCX14.11N/A
N/A
Grandeur Peak Global Micro Cap Instl
FLCOX18.51N/A
N/A
Fidelity Large Cap Value Index

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-0.05%
XENE - MLTX
47%
Loosely correlated
-2.48%
CLDX - MLTX
42%
Loosely correlated
-1.21%
DNLI - MLTX
41%
Loosely correlated
-6.91%
IDYA - MLTX
41%
Loosely correlated
-4.77%
KYMR - MLTX
39%
Loosely correlated
-10.13%
More

PHVS and

Correlation & Price change

A.I.dvisor tells us that PHVS and MLTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHVS and MLTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-0.67%
MLTX - PHVS
30%
Poorly correlated
-0.05%
AVTE - PHVS
26%
Poorly correlated
-0.20%
ARVN - PHVS
25%
Poorly correlated
-3.90%
ORIC - PHVS
25%
Poorly correlated
-9.26%
ATXS - PHVS
25%
Poorly correlated
-6.61%
More